Revisiting the role of cladribine in acute myeloid leukemia: An improvement on past accomplishments or more old news?
Author:
Affiliation:
1. Department of Pharmacy; Roswell Park Cancer Institute; Buffalo New York
2. Department of Medicine; SUNY-UB School of Medicine; Buffalo New York
3. Department of Medicine, Leukemia Service; Roswell Park Cancer Institute; Buffalo New York
Funder
National Cancer Center
National Cancer Institute
Publisher
Wiley
Subject
Hematology
Reference83 articles.
1. http://www.nccn.org/professionals/physician_gls/pdf/aml.pdf
2. Adenosine-deaminase deficiency in two patients with severely impaired cellular immunity;Giblett;Lancet,1972
3. Antileukemic and immunosuppressive activity of 2-chloro-2'-deoxyadenosine;Carson;Proc Natl Acad Sci USA,1984
4. Specific toxicity of 2-chlorodeoxyadenosine toward resting and proliferating human lymphocytes;Carson;Blood,1983
5. Nucleoside transporters in chronic lymphocytic leukaemia;Pastor-Anglada;Leukemia,2004
Cited by 36 articles. 订阅此论文施引文献 订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献
1. Impact of cladribine, cytarabine, and G-CSF (CLAG) as a bridging therapy prior to allogeneic hematopoietic stem cell transplantation in relapsed or refractory acute myeloid leukemia;Annals of Hematology;2024-05-17
2. CLAG combined with total body irradiation as intensive conditioning chemotherapy prior to allogeneic hematopoietic stem cell transplantation in patients with refractory or relapsed acute myeloid leukemia;Annals of Hematology;2023-10-17
3. Synergistic effect of HDAC inhibitor Chidamide with Cladribine on cell cycle arrest and apoptosis by targeting HDAC2/c-Myc/RCC1 axis in acute myeloid leukemia;Experimental Hematology & Oncology;2023-02-27
4. Safety and efficacy of a modified busulfan/cyclophosphamide conditioning regimen incorporating cladribine for autologous hematopoietic stem cell transplantation in acute myeloid leukemia;Frontiers in Pharmacology;2023-02-03
5. Management and Outcomes of Blast Transformed Chronic Myelomonocytic Leukemia;Current Hematologic Malignancy Reports;2021-09-09
1.学者识别学者识别
2.学术分析学术分析
3.人才评估人才评估
"同舟云学术"是以全球学者为主线，采集、加工和组织学术论文而形成的新型学术文献查询和分析系统，可以对全球学者进行文献检索和人才价值评估。用户可以通过关注某些学科领域的顶尖人物而持续追踪该领域的学科进展和研究前沿。经过近期的数据扩容，当前同舟云学术共收录了国内外主流学术期刊6万余种，收集的期刊论文及会议论文总量共计约1.5亿篇，并以每天添加12000余篇中外论文的速度递增。我们也可以为用户提供个性化、定制化的学者数据。欢迎来电咨询！咨询电话：010-8811{复制后删除}0370
www.globalauthorid.com
TOP
Copyright © 2019-2024 北京同舟云网络信息技术有限公司 京公网安备11010802033243号 京ICP备18003416号-3